Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, NY.
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, NY; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.
Chest. 2018 Jun;153(6):1387-1395. doi: 10.1016/j.chest.2018.01.006. Epub 2018 Jan 17.
We aimed to examine short- and long-term mortality in a mixed population of patients with interstitial lung disease (ILD) with acute respiratory failure, and to identify those at lower vs higher risk of in-hospital death.
We conducted a single-center retrospective cohort study of 126 consecutive adults with ILD admitted to an ICU for respiratory failure at a tertiary care hospital between 2010 and 2014 and who did not undergo lung transplantation during their hospitalization. We examined associations of ICU-day 1 characteristics with in-hospital and 1-year mortality, using Poisson regression, and examined survival using Kaplan-Meier curves. We created a risk score for in-hospital mortality, using a model developed with penalized regression.
In-hospital mortality was 66%, and 1-year mortality was 80%. Those with connective tissue disease-related ILD had better short-term and long-term mortality compared with unclassifiable ILD (adjusted relative risk, 0.6; 95% CI, 0.3-0.9; and relative risk, 0.6; 95% CI, 0.4-0.9, respectively). Our prediction model includes male sex, interstitial pulmonary fibrosis diagnosis, use of invasive mechanical ventilation and/or extracorporeal life support, no ambulation within 24 h of ICU admission, BMI, and Simplified Acute Physiology Score-II. The optimism-corrected C-statistic was 0.73, and model calibration was excellent (P = .99). In-hospital mortality rates for the low-, moderate-, and high-risk groups were 33%, 65%, and 96%, respectively.
We created a risk score that classifies patients with ILD with acute respiratory failure from low to high risk for in-hospital mortality. The score could aid providers in counseling these patients and their families.
我们旨在研究患有急性呼吸衰竭的间质性肺疾病(ILD)的混合人群的短期和长期死亡率,并确定那些住院期间院内死亡风险较低和较高的患者。
我们对 2010 年至 2014 年期间在一家三级保健医院因呼吸衰竭而入住 ICU 的 126 例连续成人ILD 患者进行了单中心回顾性队列研究,这些患者在住院期间未进行肺移植。我们使用泊松回归检查 ICU 第 1 天特征与住院和 1 年死亡率的相关性,并使用 Kaplan-Meier 曲线检查生存情况。我们使用 penalized 回归建立了一个用于院内死亡率的风险评分模型。
院内死亡率为 66%,1 年死亡率为 80%。与无法分类的ILD 相比,结缔组织病相关ILD 的短期和长期死亡率更好(调整后的相对风险,0.6;95%CI,0.3-0.9;和相对风险,0.6;95%CI,0.4-0.9)。我们的预测模型包括男性、间质性肺纤维化诊断、使用有创机械通气和/或体外生命支持、ICU 入院后 24 小时内无法行走、BMI 和简化急性生理学评分 II。经校正后的 C 统计量为 0.73,模型校准良好(P=0.99)。低危、中危和高危组的院内死亡率分别为 33%、65%和 96%。
我们创建了一个风险评分,该评分将急性呼吸衰竭的ILD 患者分为低、中、高风险的院内死亡风险。该评分可以帮助提供者为这些患者及其家属提供咨询。